Literature DB >> 2202311

The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

G G Hunder1, D A Bloch, B A Michel, M B Stevens, W P Arend, L H Calabrese, S M Edworthy, A S Fauci, R Y Leavitt, J T Lie.   

Abstract

Criteria for the classification of giant cell (temporal) arteritis were developed by comparing 214 patients who had this disease with 593 patients with other forms of vasculitis. For the traditional format classification, 5 criteria were selected: age greater than or equal to 50 years at disease onset, new onset of localized headache, temporal artery tenderness or decreased temporal artery pulse, elevated erythrocyte sedimentation rate (Westergren) greater than or equal to 50 mm/hour, and biopsy sample including an artery, showing necrotizing arteritis, characterized by a predominance of mononuclear cell infiltrates or a granulomatous process with multinucleated giant cells. The presence of 3 or more of these 5 criteria was associated with a sensitivity of 93.5% and a specificity of 91.2%. A classification tree was also constructed using 6 criteria. These criteria were the same as for the traditional format, except that elevated erythrocyte sedimentation rate was excluded, and 2 other variables were included: scalp tenderness and claudication of the jaw or tongue or on deglutition. The classification tree was associated with a sensitivity of 95.3% and specificity of 90.7%.

Entities:  

Mesh:

Year:  1990        PMID: 2202311     DOI: 10.1002/art.1780330810

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  469 in total

1.  Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis.

Authors:  L Nelimarkka; H Salminen; T Kuopio; S Nikkari; T Ekfors; J Laine; L Pelliniemi; H Järveläinen
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

2.  Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.

Authors:  M Kaiser; B Younge; J Björnsson; J J Goronzy; C M Weyand
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

Review 3.  Polymyalgia rheumatica/temporal arteritis: recent advances.

Authors:  Maria-Louise Barilla-LaBarca; Deborah J Lenschow; Richard D Brasington
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

4.  The suitability of the ultrasound biomicroscope for establishing texture in giant cell arteritis.

Authors:  S Roters; P Szurman; B F Engels; R Brunner
Journal:  Br J Ophthalmol       Date:  2001-08       Impact factor: 4.638

5.  Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications.

Authors:  P Riordan-Eva; K Landau; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

6.  A 69-year-old woman with intermittent claudication and elevated ESR.

Authors:  M L Amoedo; M P Marco; M D Boquet; S Muray; J M Piulats; M J Panades; J Ramos; E Fernandez
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

7.  Giant Cell Arteritis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-06

8.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

9.  [A 79-year-old man with B symptoms and jaw claudication].

Authors:  S Krug; I Portig; D Librizzi; A Pfestroff; T Gress; P Michl
Journal:  Internist (Berl)       Date:  2013-02       Impact factor: 0.743

10.  Overall and cause-specific mortality in giant cell arteritis : A meta-analysis.

Authors:  Y H Lee; G G Song
Journal:  Z Rheumatol       Date:  2018-12       Impact factor: 1.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.